Plain-English translation of NCT05843695 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a type of therapy called transdiagnostic cognitive behavioral therapy (CBT), delivered in an intensive two-week format for veterans and service members with PTSD and anxiety disorders. The study compares two ways of delivering this treatment: one-on-one sessions and group sessions. The goal is to see if this concentrated approach helps people recover faster and actually engage with treatment better than traditional weekly therapy.
Many veterans with PTSD and anxiety struggle with daily life, social connections, and work, but traditional therapy requires weekly visits over several months—which can be hard to stick with. This trial tests whether delivering the same proven therapy in a concentrated two-week period might help more people complete treatment and feel better.
You likely qualify if…
You likely don't qualify if…
If you join this study, you'll be randomly assigned to receive therapy either one-on-one or in a group setting. Either way, you'll attend four three-hour sessions over two weeks, learning skills to manage anxiety and PTSD through education, changing unhelpful thought patterns, and gradual exposure to feared situations. If you don't improve enough after these sessions, you may receive four additional 90-minute sessions to dive deeper into areas you find most challenging.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United States